Moreover, depletion or pharmacological inhibition of HDAC3 triggered apoptosis in cutaneous T-cell lymphoma and multiple myeloma [36, 37]. Here, HDAC3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.